Takeda Canada Inc. ("Takeda") is pleased to announce that FRUZAQLATM (fruquintinib capsules) will now be reimbursed by BC Cancer as a treatment option for adult patients with metastatic colorectal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback